We are live on
!
Find out more
H
HoyleCohen Portfolio holdings
AUM
$1.32B
1-Year Est. Return
27.05%
This Fund
S&P 500
This Quarter
Est. Return
+8.57%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
–
AUM
$1B
AUM Growth
+$91.5M
(+10%)
Cap. Flow
+$37.7M
Cap. Flow
% of AUM
3.75%
Top 10 Holdings %
Top 10 Hldgs %
29.49%
Holding
273
New
16
Increased
96
Reduced
114
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capital Group Global Growth Equity ETF
CGGO
|
+$17.7M |
| 2 |
Capital Group Growth ETF
CGGR
|
+$10.2M |
| 3 |
Capital Group Dividend Value ETF
CGDV
|
+$5.78M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$2.3M |
| 5 |
Vanguard Value ETF
VTV
|
+$2.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$2.09M |
| 2 |
Applied Materials
AMAT
|
+$1.13M |
| 3 |
Microsoft
MSFT
|
+$1.04M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$843K |
| 5 |
Vanguard Total World Stock ETF
VT
|
+$786K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.11% |
| 2 | Financials | 11.86% |
| 3 | Healthcare | 10.01% |
| 4 | Industrials | 6.6% |
| 5 | Energy | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Oneok
OKE
$58.8B
| $11.3M | 1.12% |
171,768
+793
| +0.5% | +$48.7K |
|
|
27
Capital Group Growth ETF
CGGR
$23.4B
| $10.2M | 1.01% |
510,146
+499,266
| +4,589% | +$10.2M |
|
28
Blackstone
BX
$103B
| $10.1M | 1.01% |
136,125
-84
| -0.1% | -$7.25K |
|
29
Honeywell
HON
$77.1B
| $10M | 1% |
49,549
-54
| -0.1% | -$10.3K |
|
30
ExxonMobil
XOM
$649B
| $9.84M | 0.98% |
89,180
-1,612
| -2% | -$173K |
|
31
Verizon
VZ
$192B
| $9.26M | 0.92% |
234,915
+3,576
| +2% | +$135K |
|
32
Enterprise Products Partners
EPD
$83.8B
| $9.19M | 0.91% |
381,101
-2,467
| -0.6% | -$60.7K |
|
|
33
Vanguard S&P 500 ETF
VOO
$967B
| $8.96M | 0.89% |
25,500
+6,522
| +34% | +$2.3M |
|
34
Goldman Sachs
GS
$313B
| $8.43M | 0.84% |
24,547
-209
| -0.8% | -$72.8K |
|
35
Vanguard Small-Cap ETF
VB
$79.5B
| $8.22M | 0.82% |
44,780
+1,287
| +3% | +$239K |
|
36
W.P. Carey
WPC
$17B
| $8.18M | 0.81% |
106,833
-31
| -0% | -$2.33K |
|
37
Abbott
ABT
$180B
| $7.78M | 0.77% |
70,846
+166
| +0.2% | +$17.2K |
|
38
Vanguard Total Stock Market ETF
VTI
$653B
| $7.77M | 0.77% |
40,634
-997
| -2% | -$192K |
|
39
Bristol-Myers Squibb
BMY
$127B
| $7.74M | 0.77% |
107,564
-723
| -0.7% | -$54.5K |
|
40
Vanguard Growth ETF
VUG
$216B
| $7.34M | 0.73% |
206,580
-396
| -0.2% | -$14.6K |
|
41
Thermo Fisher Scientific
TMO
$211B
| $7.26M | 0.72% |
13,180
+83
| +0.6% | +$44K |
|
|
SCHW
42
Charles Schwab
SCHW
$177B
| $7.17M | 0.71% |
86,064
-787
| -0.9% | -$61.1K |
|
43
RTX Corp
RTX
$288B
| $7.13M | 0.71% |
70,644
-446
| -0.6% | -$42K |
|
44
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $6.93M | 0.69% |
177,659
+21,327
| +14% | +$813K |
|
45
NVIDIA
NVDA
$4.98T
| $6.76M | 0.67% |
462,310
-28,210
| -6% | -$414K |
|
46
Invesco S&P 500 Equal Weight ETF
RSP
$96B
| $6.68M | 0.66% |
47,298
-2,354
| -5% | -$329K |
|
|
47
Applied Materials
AMAT
$424B
| $6.58M | 0.65% |
67,555
-11,818
| -15% | -$1.13M |
|
48
Kinder Morgan
KMI
$73.2B
| $6.44M | 0.64% |
356,139
-1,572
| -0.4% | -$28.3K |
|
49
Linde
LIN
$237B
| $6.13M | 0.61% |
18,800
-511
| -3% | -$160K |
|
50
Simon Property Group
SPG
$74.3B
| $6.12M | 0.61% |
52,115
+923
| +2% | +$103K |
|
Similar funds
PRIG
HIG
PO
BPCA
GP
AT
KI
CDH
HoyleCohen's Q4 2022 Portfolio in Review
As of Q4 2022, HoyleCohen held 273 positions worth $1B, up 10% from $913M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
HoyleCohen deployed $37.7M of net new capital in Q4 2022, opening 16 new positions and adding to 96 existing holdings. Its largest new stake was Capital Group Dividend Value ETF: 252,037 shares worth $5.95M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was AbbVie, an estimated $2.09M trimmed.
- HoyleCohen's largest Q4 2022 buy was Capital Group Dividend Value ETF: 252,037 shares worth $5.95M.
- HoyleCohen added most to Capital Group Global Growth Equity ETF in Q4 2022, an estimated $17.7M increase.
- HoyleCohen's biggest Q4 2022 reduction was AbbVie, cutting an estimated $2.09M.
- HoyleCohen fully exited iShares S&P Small-Cap 600 Value ETF in Q4 2022, selling an estimated $398K.
- HoyleCohen's ten largest holdings make up 29% of its $1B portfolio in Q4 2022.
- HoyleCohen opened 16 new positions and closed 9 in Q4 2022.
- HoyleCohen's portfolio value rose 10% quarter-over-quarter to $1B.
Based on HoyleCohen's 13F filing for Q4 2022, filed 14 Feb 2023.